Eytan Ruppin

National Institutes of Health — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

97h-index33.5kcitations1.0kworks3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(212), Cancer Immunotherapy and Biomarkers(179), Epigenetics and DNA Methylation(132), Bioinformatics and Genomic Networks(106), CAR-T cell therapy research(100)

Publications1.0k total

The molecular cartography of malignant and benign sebaceous tumours
Nature Communications·2025Open Access
Supplementary Table 3 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S1 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S5 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S14 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Data from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S9 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S7 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Table 4 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S17 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S15 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S16 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S2 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S10 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Table 2 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S12 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S6 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Table 1 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S11 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S3 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
page 1 of 52Next →

Frequent Co-authors

Tomer Shlomi(12), Roded Sharan(9), Eyal Gottlieb(7), Joo Sang Lee(6), Martin Kupiec(6), Livnat Jerby(4), Isaac Meilijson(4), Zach Solan(3), Assaf Gottlieb(3), Tamir Tuller(3), Uri Gophna(3), Liang Zheng(3), Christian Frezza(3), Eilon Barnea(3), Ronen Levy(3), Arie Admon(3), Yardena Samuels(3), Keren Yizhak(3), Lev Finkelstein(2), Evgeniy Gabrilovich(2)